Kelley Dealhoy
Chatham, New Jersey, United States
2K followers
500+ connections
Chatham, New Jersey, United States
2K followers
500+ connections
Activity
-
I am very excited to share that I am starting a new position as a Partner in the Strategy, Marketing and Innovation Practice at the Partnering Group.…
I am very excited to share that I am starting a new position as a Partner in the Strategy, Marketing and Innovation Practice at the Partnering Group.…
Liked by Kelley Dealhoy
-
Exciting day today! Looking forward to a bright future where together we can help even more patients!
Exciting day today! Looking forward to a bright future where together we can help even more patients!
Shared by Kelley Dealhoy
-
It’s official! Thanks to our people, Deciphera is proud to have earned #GreatPlaceToWork certification for the second year in a row in the United…
It’s official! Thanks to our people, Deciphera is proud to have earned #GreatPlaceToWork certification for the second year in a row in the United…
Liked by Kelley Dealhoy
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Publications
-
External innovation: How biopharma companies are bolstering R&D pipelines through deal-making
Deloitte Insights
Sourcing research externally seems to be the preferred path for biopharma companies to strengthen their R&D pipeline. But when choosing from the three main options open to them—licensing, mergers and acquisitions, and joint ventures—what factors should they examine, and do deal types differ in the ways they accelerate development and deliver long-term value?
Other authors -
More activity by Kelley
-
Madeline Simpson and Ian Parrag presented results of RIPPLE-1 @ARVO2024. RIPPLE-1 was a first-in-human phase II, multi-center, single-masked…
Madeline Simpson and Ian Parrag presented results of RIPPLE-1 @ARVO2024. RIPPLE-1 was a first-in-human phase II, multi-center, single-masked…
Liked by Kelley Dealhoy
-
Our CEO, Tom Reeves was very pleased to share the Ripple story at #OISRetina Innovation Summit with such an esteemed group. Treat early. Treat less…
Our CEO, Tom Reeves was very pleased to share the Ripple story at #OISRetina Innovation Summit with such an esteemed group. Treat early. Treat less…
Liked by Kelley Dealhoy
-
We are delighted to welcome Mireia G. to Numab Therapeutics AG as a Chief Business Officer. Her insights as an accomplished biopharma executive and…
We are delighted to welcome Mireia G. to Numab Therapeutics AG as a Chief Business Officer. Her insights as an accomplished biopharma executive and…
Liked by Kelley Dealhoy
-
At Ripple, we are grateful for our co-op students. We’ve had 21 students since Summer 2021 work in our labs for 4-16 month terms. We’re thankful for…
At Ripple, we are grateful for our co-op students. We’ve had 21 students since Summer 2021 work in our labs for 4-16 month terms. We’re thankful for…
Liked by Kelley Dealhoy
-
I couldn’t be more excited to join Actym Therapeutics as its CEO. Thanks to the exceptional efforts of the team, Actym is on the brink of becoming a…
I couldn’t be more excited to join Actym Therapeutics as its CEO. Thanks to the exceptional efforts of the team, Actym is on the brink of becoming a…
Liked by Kelley Dealhoy
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More